Direxion Daily S&P Biotech Bear 3X ETF
LABD
8 hedge funds and large institutions have $5.78M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
167% more funds holding
Funds holding: 3 → 8 (+5)
78% more capital invested
Capital invested by funds: $3.25M → $5.78M (+$2.53M)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.02% less ownership
Funds ownership: 0.03% → 0.01% (-0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.27M |
| 2 |
VF
Virtu Financial
New York
|
+$637K |
| 3 |
CT
CMT Trading
Chicago,
Illinois
|
+$212K |
| 4 |
FWSM
First Wilshire Securities Management
Pasadena,
California
|
+$212K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$70.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$2.2M |
| 2 |
Jane Street
New York
|
-$70.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $2.4M | +$637K | +9 | +75% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $2.03M | +$1.27M | +18 | New |
|
|
3
Jane Street
New York
| $509K | -$70.8K | -1 | -20% |
|
|
CT
4
CMT Trading
Chicago,
Illinois
| $286K | +$212K | +3 | New |
|
|
FWSM
5
First Wilshire Securities Management
Pasadena,
California
| $286K | +$212K | +3 | New |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $113K | +$70.8K | +1 | New |
|
|
7
Bank of Montreal
Toronto,
Ontario, Canada
| $86K | +$70.8K | +1 | New |
|
8
UBS Group
Zurich,
Switzerland
| $71K | +$70.8K | +1 | New |
|
|
9
Citigroup
New York
| – | -$2.2M | -35 | Closed |
|
LABD Hedge Fund Activity: Q3 2015 in Review
8 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q3 2015, worth a combined $5.78M — up 78% from $3.25M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new LABD positions and 1 closed out — a net gain of 5 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.27M. The largest seller was Citigroup, exiting entirely with an estimated $2.2M sold.
- 8 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q3 2015, up from 3 in Q2 2015.
- Funds reported $5.78M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q3 2015, up 78% quarter-over-quarter.
- 6 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q3 2015 and 1 closed out, a net change of +5 holders.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q3 2015 was Susquehanna International Group, an estimated $1.27M added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q3 2015 was Citigroup, an estimated $2.2M sold.
Based on aggregated 13F filings for Q3 2015.